George Yancopoulos, President Regeneron Laboratori at REGENERON PHARMACEUTICALS INC (REGN), sold 139,470 shares at $561.75 ($78.5M) on 2015-11-02, disclosed to the SEC on 2015-11-03.
Scheduled sale ($78.5M) by President Regeneron Laboratori under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $559.08 | 92,316 | $51.6M | 65.7% |
| 2 | $559.08 | 3,806 | $2.1M | 2.7% |
| 3 | $561.75 | 1,200 | $674K | 0.9% |
| 4 | $562.36 | 100 | $56K | 0.1% |
| 5 | $563.76 | 530 | $299K | 0.4% |
| 6 | $564.57 | 1,000 |
| $565K |
| 0.7% |
| 7 | $565.89 | 1,000 | $566K | 0.7% |
| 8 | $566.66 | 1,700 | $963K | 1.2% |
| 9 | $567.61 | 1,350 | $766K | 1.0% |
| 10 | $568.49 | 1,600 | $910K | 1.2% |
| 11 | $569.47 | 2,223 | $1.3M | 1.6% |
| 12 | $570.67 | 6,330 | $3.6M | 4.6% |
| 13 | $571.41 | 7,800 | $4.5M | 5.7% |
| 14 | $572.43 | 5,723 | $3.3M | 4.2% |
| 15 | $573.47 | 2,629 | $1.5M | 1.9% |
| 16 | $574.55 | 2,693 | $1.5M | 2.0% |
| 17 | $575.64 | 2,441 | $1.4M | 1.8% |
| 18 | $576.48 | 865 | $499K | 0.6% |
| 19 | $577.58 | 1,996 | $1.2M | 1.5% |
| 20 | $578.73 | 268 | $155K | 0.2% |
| 21 | $579.53 | 1,500 | $869K | 1.1% |
| 22 | $580.29 | 400 | $232K | 0.3% |
| Total | $562.97 avg | 139,470 | $78.5M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |